Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
The correction was performed according to Eq
Boehringer Ingelheim International GmbH Scope of Report GLP-1 Receptor Agonist Market Analysis by Segments Drug: Semaglutide Exenatide Lixisenatide Liraglutide Dulaglutide Others Route of Administration: Oral Parenteral Indication: Diabetes Obesity Others Distribution Channel: Hospital Pharmacies Retail Pharmacies Online Pharmacies Region: North America Latin America Europe Asia-Pacific Middle East & Africa Bibliography Pharmaceutical Executive
Licensed indications for the use of alternative GLP-1 RAs or the dual GIP/GLP-1 RA tirzepatide
- Wrong, damaged, or faulty items: Contact us as soon as possible, ideally within a few days of delivery, for free return shipping and a full refund or replacement
US$ 27.10
US$ 27.25
US$ 21.18
